Karlsson, P; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Collins, J; Murray, E; Zaman, K; Colleoni, M; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Annals of oncology, 22(10), pp. 2216-26. Oxford: Oxford University Press 10.1093/annonc/mdq735
|
Text
mdq735.pdf - Published Version Available under License Publisher holds Copyright. Download (658kB) | Preview |
The International Breast Cancer Study Group Trial VIII compared long-term efficacy of endocrine therapy (goserelin), chemotherapy [cyclophosphamide, methotrexate and fluorouracil (CMF)], and chemoendocrine therapy (CMF followed by goserelin) for pre/perimenopausal women with lymph-node-negative breast cancer.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Rabaglio, Manuela Elena |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:20 |
Last Modified: |
02 Mar 2023 23:20 |
Publisher DOI: |
10.1093/annonc/mdq735 |
PubMed ID: |
21325445 |
Web of Science ID: |
000295168500008 |
BORIS DOI: |
10.7892/boris.6469 |
URI: |
https://boris.unibe.ch/id/eprint/6469 (FactScience: 211435) |
Actions (login required)
 |
Edit item |